论文部分内容阅读
铂类为基础的同步放化疗在美国国立综合癌症网络(NCCN)指南中被认为是局部晚期宫颈癌的标准治疗方案,而在欧洲、日本、韩国以及拉丁美洲,局部晚期宫颈癌的其他治疗方式被认为具有同样的治疗效果。目前我国医疗机构水平参差不齐,放疗设备不一,新辅助化疗(NACT)联合放疗或同步放化疗不失为一种可选择的方法。不可忽视手术在局部晚期宫颈癌中的作用,新辅助化疗仅是局部晚期宫颈癌综合治疗措施中的一部分,临床应用需谨慎,不可滥用,不能将NACT作为单一的、主要的治疗手段。
Platinum-based concurrent chemoradiotherapy is considered the standard treatment for locally advanced cervical cancer in the National Comprehensive Cancer Network (NCCN) guidelines and in Europe, Japan, South Korea, and Latin America, other forms of treatment for locally advanced cervical cancer Is considered to have the same therapeutic effect. At present, the level of medical institutions in our country is uneven with different radiotherapy equipment. Neoadjuvant chemotherapy (NACT) combined with radiotherapy or concurrent chemoradiotherapy is an alternative method. The role of surgery in locally advanced cervical cancer can not be ignored. Neoadjuvant chemotherapy is only a part of the comprehensive treatment for locally advanced cervical cancer. The clinical application should be cautious and can not be abused. NACT can not be used as a single, major treatment.